Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 444 results found. Search for [ Zydus ]

Results 1 to 21 of 444
BusinessToday.In
October 20, 2020
India Stock Market Highlights Today: HCL Tech, followed by L&T, M&M, Tech Mahindra, Maruti, TCS, Asian Paints, Infosys and HDFC Bank were among the top gainers today. On the other hand, ONGC, Nestle India, SBI, ICICI Bank and IndusInd Bank were among the laggards


BusinessToday.In
October 19, 2020
India Stock Market Highlights Today: ONGC, followed by NTPC, HDFC, Axis Bank, ICICI Bank, PowerGrid and Nestle India were among the top gainer on Sensex pack. On the other hand, TCS, Tech Mahindra, Infosys and Sun Pharma were among the laggards.


BusinessToday.In
October 19, 2020
Stocks to watch today on October 19: HDFC Bank, Tata Communications, Avenue Supermarts, Bajaj Consumer, RIL among others are the top stocks to watch out for in Monday's trading session


BusinessToday.In
October 17, 2020
The shots planned for the initial phase would include a booster dose as well. The list comprises four categories of beneficiaries including frontline workers, healthcare professionals, people above 50, and people with comorbidities


BusinessToday.In
October 16, 2020
Cadila Healthcare share gained up to 3.99% to Rs 432.20 against previous close of Rs 415.60 on BSE


BusinessToday.In
October 16, 2020
Ivermectin, a drug used to treat lice and other parasites, has shown some promising results against coronavirus, claims a specialist from Melbourne


BusinessToday.In
October 16, 2020
The WHO said that the Solidarity trial looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalised patients


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Bharat Biotech is ready to start Covaxin's Phase 3 trail to test the vaccine on about 28,500 volunteers


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Biopharma company Epygen Biotech with operations in Mumbai and Dubai is planning to launch an affordable COVID-19 vaccine with an aim to roll out 500 million doses within six months


Joe C Mathew
October 13, 2020
In most cases, AstraZeneca gathered information about marketing approvals from the state departments by using the RTI (Right to Information Act) route


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


PTI
October 10, 2020
According to sources, the phase-2 trial of the Covaxin is going on and the second dose is yet to be given to volunteers at some sites


Reuters
October 6, 2020
The Hyderabad-based pharmaceutical company had applied to the Drugs Controller General of India (DCGI) late last week, seeking permission to conduct phase-3 human clinical trials of the Russian vaccine


BusinessToday.In
October 5, 2020
Stocks to watch today on October 5: Angel Broking, RIL, TCS, NMDC, Dr Reddy's among others are the top stocks to watch out for in Monday's trading session


BusinessToday.In
October 4, 2020
COVID-19 vaccine update: The Centre is deliberating allowing companies to secure vaccine doses directly and early on to ensure that there is no disruption of key economic activities


BusinessToday.In
October 3, 2020
COVID-19 vaccine: A principal investigator from a trial site in Maharashtra said that they are expecting to finish enrolling the participants within the next two months after which they will be monitored for the vaccine's efficacy


BusinessToday.In
October 2, 2020
Coronavirus cases in India: The active patients' tally in India stands at 9,42,217; around 53,52,078 patients have recovered and 99,773 have succumbed to the deadly virus so far


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


BusinessToday.In
September 28, 2020
The government is going to assess efficacy data of all concerned companies (working on COVID-19 vaccines) before inking a purchase contract with them and will buy vaccines at least for essential workers


PAGES 1 OF 23  12345